Infectious Disease Connect and ILÚM Health Solutions Combine to Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship
Agreement Includes Strategic Investments from UPMC Enterprises and Merck Global Health Innovation Fund
KENILWORTH, N.J. & PITTSBURGH–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and UPMC today announced that Infectious Disease Connect Inc., a UPMC-backed company offering telemedicine-enabled solutions to hospitals for treatment of infectious diseases, has combined with Merck’s ILÚM Health Solutions, a provider of technology and services to support infectious disease management, clinical decision-support and precision antibiotic therapy.
UPMC Contact:
Courtney Caprara
Office: 412-647-6190
Mobile: 412-592-8134
E-mail: [email protected]
UPMC Contact:
Wendy Zellner
Office: 412-586-9777
Mobile: 412-973-7266
Email: [email protected]
Merck Media Contact:
Pamela Eisele
267-305-3558
Merck Investor Relations Contact:
Peter Dannenbaum
908-740-1037